Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure

Autor: Stefanou, Charalambos, Pieri, Myrtani, Savva, Isavella, Georgiou, Georgios C., Pierides, Alkis M., Voskarides, Konstantinos, Constantinou-Deltas, Constantinos D.
Přispěvatelé: Constantinou-Deltas, Constantinos D. [0000-0001-5549-9169]
Rok vydání: 2015
Předmět:
Male
urologic and male genital diseases
Autoantigens
Cohort Studies
Focal segmental glomerulosclerosis
middle aged
Glomerular Basement Membrane
genetics
membrane protein
Proteinuria
biology
Glomerulosclerosis
Focal Segmental

Glomerular basement membrane
disease course
allele
Intracellular Signaling Peptides and Proteins
pedigree
Middle Aged
cohort analysis
female genital diseases and pregnancy complications
autoantigen
Pedigree
aged
medicine.anatomical_structure
female
Disease Progression
Female
medicine.symptom
focal glomerulosclerosis
Collagen Type IV
medicine.medical_specialty
Heterozygote
sex difference
Inheritance (object-oriented programming)
Sex Factors
male
collagen type 4
Internal medicine
medicine
Humans
signal peptide
human
Alleles
Aged
business.industry
urogenital system
Membrane Proteins
medicine.disease
type IV collagen alpha3 chain
heterozygote
Endocrinology
Mutation
Podocin
biology.protein
glomerulus basement membrane
Kidney Failure
Chronic

pathology
proteinuria
mutation
business
podocin
Zdroj: Nephron
ISSN: 2235-3186
Popis: Background/Aims: A subset of patients who present with proteinuria and are diagnosed with focal segmental glomerulosclerosis (FSGS) have inherited heterozygous COL4A3/A4 mutations and are also diagnosed with thin basement membrane nephropathy (TBMN-OMIM: 141200). Two studies showed that co-inheritance of NPHS2-p.Arg229Gln, a podocin variant, may increase the risk for proteinuria and renal function decline. Methods: We hypothesized that additional podocin variants may exert a similar effect. We studied genetically a well-characterized Cypriot TBMN patient cohort by re-sequencing the NPHS2 coding region. We also performed functional studies in cell culture experiments, investigating the interaction of podocin variants with itself and with nephrin. Results: Potentially disease-modifying podocin variants were searched for by analyzing NPHS2 in 35 ‘severe' TBMN patients. One non-synonymous variant, p.Glu237Gln, was detected. Both variants, p.Arg229Gln and p.Glu237Gln, were tested in a larger cohort of 122 TBMN patients, who were categorized as ‘mild' or ‘severe' based on the presence of microscopic hematuria alone or combined with chronic renal failure and/or proteinuria. Seven ‘severe' patients carried either of the 2 variants; none was present in the ‘mild' patients (p = 0.05, Pearson χ2). The 7 carriers belong in 2 families segregating mutation COL4A3-p.Gly1334Glu. Inheritance of the wild-type (WT) and mutant alleles correlated with the phenotype (combined concordance probability 0.003). Immunofluorescence (IF) experiments after dual co-transfection of WT and mutant podocin suggested altered co-localization of mutant homodimers. IF experiments after co-transfection of WT podocin and nephrin showed normal membrane localization, while both podocin variants interfered with normal trafficking, demonstrating perinuclear staining. Immunoprecipitation experiments showed stronger binding of mutant podocin to WT podocin or nephrin. Conclusion: The results support the hypothesis that certain hypomorphic podocin variants may act as adverse genetic modifiers when co-inherited with COL4A3/A4 mutations, thus predisposing to FSGS and severe kidney function decline.
Databáze: OpenAIRE